-
Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
-
Long-term safety and efficacy of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects: results of a Phase III study
-
Long-Term Treatment With Deutetrabenazine (DTBZ) Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From the Completed, 3-year Open-Label Extension (OLE) Study
-
Longitudinal association between UPDRS and health-related quality of life in people with Parkinson´s disease
-
Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder
-
Longitudinal clinical and imaging characteristics of non-manifest LRRK2 carriers: The PPMI cohort
-
Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF study
-
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients and controls: the PPMI study
-
Longitudinal Utility of the Montreal Cognitive Assessment and Mini Mental State Exam in Huntington’s disease (HD)
-
Look Again: The Diagnostic Value of Repeat Dopamine Transporter Imaging
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 149
- Next Page »